A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
/in Dendritic Cells, Hypernephroma, International Publications /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).
/in Dendritic Cells, Hypernephroma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3085)Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).
/in Dendritic Cells, Hypernephroma, International Publications, Soft Tissue Sarcoma /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling
/in Hypernephroma, International Publications, Newcastle Disease Virus /von 2013-03-18 / J. Interferon Cytokine Res. 2013 Jul;33(7):346-54Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study
/in Dendritic Cells, Hypernephroma, International Publications /von 2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-27Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
/in Dendritic Cells, Hypernephroma, International Publications /von 2012-06-01 / J Clin Oncol 30, 2012 (suppl; abstr e15053)Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2012-01-26 / Cancer Immunol. Immunother. 2012 Sep;61(9):1407-13Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
/in Breast Cancer, Dendritic Cells, Hypernephroma, International Publications /von 2011-10-20 / J Transl Med 2011 Oct;9:178Proving the principle: dendritic cell-based vaccines in urogenital cancers
/in Dendritic Cells, Hypernephroma, International Publications, Prostate Cancer /von 2011-10-01 / Expert Rev Vaccines 2011 Oct;10(10):1355-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de